PATENT CLAIM ANALYSIS

Application Number: 15758662
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "078170"]

Abstract:
The present invention relates in general to polymer-bioactive agent conjugates for delivering a bioactive agent to a subject. The polymer-bioactive agent conjugates contain triazole moieties in the polymer backbone and a bioactive moiety selected from quinolones, NSAIDs and mixtures thereof. The present invention also relates to methods for preparing the polymer conjugates using click cycloaddition chemical reactions, to monomer-bioactive agent conjugates suitable for preparing the polymer conjugates, and to pharmaceutical products comprising the polymer conjugates for the post-surgical care to treat or prevent infections, provide analgesia and treat inflammation.

Claim (Index 52):
A polymer-bioactive agent conjugate according to  claim 42 , wherein D is the acid residue of a carboxylic acid NSAID selected from aceclofenac, alminoprofen, amfenac, bromfenac, carprofen, diclofenac, enfenamic acid, etodolac, flufenamic acid, meclofenamic acid, mefenamic acid, niflumic acid, tolfenamic acid, bendazac, benoxaprofen, bermoprofen, bucloxic acid, butibufen, cinmetacin, clidanac, clopirac, dexibuprofen, dexketoprofen, felbinac, fenbufen, fenclozic acid, fenoprofen, fentiazac, flunoxaprofen, flunixin, flurbiprofen, ibuprofen, indomethacin, isofezolac, isoxepac, ketoprofen, licofelone, lonazolac, loxoprofen, lumiracoxib, metiazinic acid, mofezolac, naproxen, oxaprozin, pirazolac, pirprofen, pranoprofen, protizinic acid, sulindac, suprofen, tiaprofenic acid, tolmetin, bermoprofen, bucloxic acid, isoxepac, ketoprofen, loxoprofen, zaltoprofen, balsalazide, fendosal, olsalazine, ximoprofen, mesalamine, sulfasalazine, acetylsalicylsalicylic acid, alclofenac, aspirin, benoxaprofen, 5-bromosalicylic acid acetate, cinchophen, diacerein, dipyrocetyl, fosfosal, ibufenac, indoprofen, clometacin, ketorolac, zomepirac, actarit, clonixin, salicylamide O-acetic acid, diflunisal, gentisic acid, and salsalate.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.81132
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14772981', '15435784', '15458546', '14409612', '13082841']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8151130496170063
- 35 USC 102 Novelty (BERT): 0.5826287307048276
- Combined Prediction Score: 0.7918646177257884
- Mean Citation Score: 466.697574
- Max Citation Score: 501.03647
- Similarity Product: 426.7434866771448

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test